The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma
Abstract
In Brief Background: The Milan criteria have been adopted by United Network for Organ Sharing (UNOS) to preoperatively assess outcome in patients with hepatocellular carcinoma (HCC) who receive orthotopic liver transplantation (OLT). These criteria rely solely on radiographic appearances of the tumor, providing no measure of tumor biology. Recurrence rates, therefore, remain around 20% for patients within the criteria. The neutrophil-lymphocyte ratio (NLR) is an indicator of inflammatory status previously established as a prognostic indicator in colorectal liver metastases. We aimed to determine whether NLR predicts outcome in patients undergoing OLT for HCC. Design: Analysis of patients undergoing OLT for HCC between 2001 and 2007 at our institution. A NLR ≥5 was considered to be elevated. Results: A total of 150 patients were identified, with 13 patients having an elevated NLR. Of these, 62% developed recurrence compared with 14% with normal NLR (P < 0.0001). The disease-free survival for patients with high NLR was significantly worse than that for patients with normal NLR (1-, 3-, and 5-year survivals of 38%, 25%, and 25% vs. 92%, 85%, and 75%, P < 0.0001). Patients with high NLR also had poorer overall survival (5-year survival, 28% vs. 64%, P = 0.001). Patients within Milan with an elevated NLR had significantly poorer disease-free survival than those with normal NLR within Milan (5-year survival, 30% vs. 81%, P < 0.0001). On univariate analysis, 9 factors including an NLR ≥5 were significant predictors of poor disease-free survival. However, only a raised NLR remained significant on multivariate analysis (P = 0.005, HR: 19.98). Conclusion: Elevated NLR significantly increases the risk for tumor recurrence and recipient death. Preoperative NLR measurement may provide a simple method of identifying patients with poorer prognosis and act as an adjunct to Milan in determining, which patients benefit most from OLT. The Milan criteria assess which patients with hepatocellular carcinoma should receive liver transplants. There remains debate as to the utility of these criteria in predicting outcome as they do not include tumor biology measures. We present a novel method of preoperatively assessing outcome in patients with hepatocellular carcinoma who undergo liver transplants, using the neutrophil-lymphocyte ratio. This may act as an important adjunct to these criteria in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Jonas, S., Bechstein, W. O., Steinmüller, T., Herrmann, M., Radke, C., Berg, T., Settmacher, U., & Neuhaus, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23561 · Cited by 894
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
Walsh, S. R., Cook, E. J., Goulder, F., Justin, T. A., & Keeling, N. J. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20329 · Cited by 894
Identification of metastasis-related microRNAs in hepatocellular carcinoma
Budhu, A., Jia, H.-L., Forgues, M., Liu, C.-G., Goldstein, D., Lam, A., Zanetti, K. A., Ye, Q.-H., Qin, L.-X., Croce, C. M., et al. (2008) · Hepatology · doi:10.1002/hep.22160 · Cited by 697
The codependence of angiogenesis and chronic inflammation
Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 694
Cited by
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
“Lymphocytes play a crucial role in tumor defense by inducing cytotoxic cell death and inhibiting tumor cell proliferation and migration (16), thereby dictating the host immune response to malignancy (12).”
BackgroundThe systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.010 · Cited by 1,552
de Jager, C. P., van Wijk, P. T., Mathoera, R. B., de Jongh-Leuvenink, J., van der Poll, T., & Wever, P. C. (2010) · Critical Care · doi:10.1186/cc9309 · Cited by 672
Azab, B., Bhatt, V. R., Phookan, J., Murukutla, S., Kohn, N., Terjanian, T., & Widmann, W. D. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1814-0 · Cited by 565
Chua, W., Charles, K. A., Baracos, V. E., & Clarke, S. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.100 · Cited by 468
Motomura, T., Shirabe, K., Mano, Y., Muto, J., Toshima, T., Umemoto, Y., Fukuhara, T., Uchiyama, H., Ikegami, T., Yoshizumi, T., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.017 · Cited by 448
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Sapisochin, G., & Bruix, J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.193 · Cited by 436
Neutrophils in Cancer: Two Sides of the Same Coin
Uribe-Querol, E., & Rosales, C. (2015) · Journal of Immunology Research · doi:10.1155/2015/983698 · Cited by 422
Pinato, D. J., North, B. V., & Sharma, R. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.92 · Cited by 421
Azab, B., Camacho-Rivera, M., & Taioli, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112361 · Cited by 375
Dumitru, C. A., Moses, K., Trellakis, S., Lang, S., & Brandau, S. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1294-5 · Cited by 374
The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia
de Jager, C. P. C., Wever, P. C., Gemen, E. F. A., Kusters, R., van Gageldonk-Lafeber, A. B., van der Poll, T., & Laheij, R. J. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046561 · Cited by 328
Sharaiha, R. Z., Halazun, K. J., Mirza, F., Port, J. L., Lee, P. C., Neugut, A. I., Altorki, N. K., & Abrams, J. A. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1754-8 · Cited by 325
Self-citationParamanathan, A., Saxena, A., & Morris, D. L. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2013.12.001 · Cited by 316
Dumitru, C. A., Lang, S., & Brandau, S. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.005 · Cited by 303
Dolan, R. D., Lim, J., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16955-5 · Cited by 300
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Fushiya, N., Koike, K., Nishino, H., & Tajiri, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.354 · Cited by 293
Neutrophil-Lymphocyte Ratio as a Predictor of Adverse outcomes of Acute Pancreatitis
Azab, B., Jaglall, N., Atallah, J. P., Lamet, A., Raja-Surya, V., Farah, B., Lesser, M., & Widmann, W. D. (2011) · Pancreatology · doi:10.1159/000331494 · Cited by 282
Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story
Halazun, K. J., Najjar, M., Abdelmessih, R. M., Samstein, B., Griesemer, A. D., Guarrera, J. V., Kato, T., Verna, E. C., Emond, J. C., & Brown, R. S. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001966 · Cited by 281
“The NLR was first found to be a predictor of patient survival and recurrencefree survival (RFS) after liver transplantation by our group in 2009.(14) Several groups have since validated the utility of the NLR at predicting recurrence and outcome.”
BackgroundSelf-citationIntratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
Li, Y.-W., Qiu, S.-J., Fan, J., Zhou, J., Gao, Q., Xiao, Y.-S., & Xu, Y.-F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.044 · Cited by 268
Zha, C., Meng, X., Li, L., Mi, S., Qian, D., Li, Z., Wu, P., Hu, S., Zhao, S., Cai, J., et al. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0353 · Cited by 260
Alkhouri, N., Morris‐Stiff, G., Campbell, C., Lopez, R., Tamimi, T. A., Yerian, L., Zein, N. N., & Feldstein, A. E. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02639.x · Cited by 256
Neutrophil–Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis
Celikbilek, M., Dogan, S., Ozbakır, O., Zararsız, G., Kücük, H., Gürsoy, S., Yurci, A., Güven, K., & Yücesoy, M. (2013) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21564 · Cited by 256
Agopian, V. G., Harlander-Locke, M., Zarrinpar, A., Kaldas, F. M., Farmer, D. G., Yersiz, H., Finn, R. S., Tong, M., Hiatt, J. R., & Busuttil, R. W. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2014.12.025 · Cited by 252
Ljungström, L., Pernestig, A.-K., Jacobsson, G., Andersson, R., Usener, B., & Tilevik, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181704 · Cited by 219
Porrata, L. F., Ristow, K., Habermann, T., Inwards, D. J., Micallef, I. N., & Markovic, S. N. (2010) · American Journal of Hematology · doi:10.1002/ajh.21849 · Cited by 124
Verna, E. C., Phipps, M. M., Halazun, K. J., Markovic, D., Florman, S. S., Haydel, B. M., Ruiz, R., Klintmalm, G., Lee, D. D., Taner, B., et al. (2023) · Liver Transplantation · doi:10.1097/lvt.0000000000000007 · Cited by 16
Self-citation
Metadata
- Authors
- Halazun, K. J., Hardy, M. A., Rana, A. A., Woodland, D. C., Luyten, E. J., Mahadev, S., Witkowski, P., Siegel, A. B., Brown, R. S., & Emond, J. C.
- Venue
- Annals of Surgery
- Published
- 2009-07
- Volume
- 250
- Issue
- 1
- Pages
- 141-151
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2005041705
- Cited by
- 401
- References
- 38
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.